Moody's confirms Envision Healthcare's B1 CFR with respect to its AmSurg merger; rating outlook now positive
New York, November 04, 2016-- Moody's Investors Service today confirmed Envision Healthcare Corporation's B1 Corporate Family Rating and B1-PD Probability of Default Rating. In addition, Moody's assigned a Ba3 rating to the company's proposed $3.295 billion first lien term loan due 2023. Concurrently, Moody's is confirming the B3 ratings on Envision's outstanding $750 million 5.125% senior notes due 2022. Subsequently, Moody's expects to confirm the B3 rating on AmSurg...
Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:
- 130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations
Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.
Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.